Because EGFR is expressed in the skin and adnexal structures, EGFR inhibitors are associated with significant cutaneous adverse reactions, mainly acneiform eruption and xerosis, but also paronychia, abnormal scalp, facial hair, and eyelash growth, maculopapular rash, mucositis and post inflammatory hyperpigmentation [19]. Here, EGFR is linked to Dry skin.